| Project/Area Number |
11794017
|
|---|
| Research Category |
Grant-in-Aid for University and Society Collaboration
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Pathological medical chemistry
|
|---|
| Research Institution | Kanazawa University |
|---|
Principal Investigator |
KANEKO Shuichi Kanazawa University, Graduate School of Medicine, Associate Professor, 大学院・医学系研究科, 助教授 (60185923)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TAMIYA Eiichi Japan Advanced Institute of Science and Technology, School of Materials Science, Professor, 教授 (60179893)
NAKAMOTO Yasurari Kanazawa University, Graduate School of Medicine, Assistant Professor, 医学部・附属病院, 助手 (40293352)
HONDA Masao Kanazawa University, Graduate School of Medicine, Associate Professor, 大学院・医学系研究科, 助教授 (00272980)
ARAKAWA Hisao Hokutokagaku Co., Development, Manager, 室長(研究職)
KAWAKAMI Bunsei Toyobo Co., Gene Analysis, Chief, 主席部員(研究職)
佐々木 基 澁谷工業株式会社, 主事
|
|---|
| Project Period (FY) |
1999 – 2001
|
| Project Status |
Completed (Fiscal Year 2001)
|
| Budget Amount *help |
¥15,000,000 (Direct Cost: ¥15,000,000)
Fiscal Year 2001: ¥15,000,000 (Direct Cost: ¥15,000,000)
|
|---|
| Keywords | Biosensor / Cancer / DNA chip / SAGE / Molecular Diagnosis / 遺伝子 |
|---|
| Research Abstract |
Development of a biosensor-type-DNA chip for the diagnosis of cancer is an objective of this research. To attain this objective, two lines of research projects were designed.
For the first line of the project, we systematically examined expression profiles in the liver with various diseases including hepatocellular carcinoma. Over one hundred clinical materials were analyzed with home-made DNA chips, and the expression profile in each disease was demonstrated. This study revealed that a DNA chip analysis gives new information that cannot be obtained by routine biochemical and pathological examinations, and made the DNA chip be a new diagnostic technique, or a new tumor marker. Using serial analysis of gene expression (SAGE), over 300,000 expressed tags in the liver were obtained and deposited into databases. A DNA chip, which predicts the efficacy of drugs against chronic hepatitis C, was put on the market.
Another line of the project is to make a biosensor-type-DNA chip, which can be used in routine clinical settings on site. Using microelectrodes on a chip, target nucleic acids can be measured in liquid (applied for a patent in 2001). A small-size thermal cycler for the introduction of measurement on microelectrodes was developed (applied for a patent in 2000). A DNA spotter on a microelectrode was also developed (pending for a patent). Using these successive developments, a biosensor-type-DNA chip, which is small-size, less expensive compared with former laser-detection-type DNA chips, and faster for the clinical diagnosis, was made.
|
